Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bliss

Showing results (361-370 of 378) with videos related to

Pageof 38
Sort By:
Contemporary Clinical Trials|March 27, 2024
Getting our ducks in a row: The need for data utility comparisons of healthcare systems data for clinical trialsMatthew R Sydes, Macey L Murray, Saiam Ahmed, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2015
XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer PatientsPetra Seibold, Sabine Behrens, Peter Schmezer, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2022
Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrantLuca Malorni, Svitlana Tyekucheva, Florentine S Hilbers, et al.
The Journal of Infectious Diseases|October 23, 2014
Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individualsSusanne H Hodgson, Katie J Ewer, Carly M Bliss, et al.
The Journal of Infectious Diseases|June 17, 2016
Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAPTommy Rampling, Katie J Ewer, Georgina Bowyer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 24, 2012
ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humansSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
Pediatric Research|January 8, 2022
Neonatal sepsis: a systematic review of core outcomes from randomised clinical trialsCían J Henry, Gergana Semova, Ellen Barnes, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2017
Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and InfantsCarly M Bliss, Abdoulie Drammeh, Georgina Bowyer, et al.
Lancet (London, England)|February 20, 2007
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trialR C Coombes, L S Kilburn, C F Snowdon, et al.
Plos One|March 26, 2013
Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adultsCaroline Ogwang, Muhammed Afolabi, Domtila Kimani, et al.
Pageof 38

Showing results (361-370 of 378) with videos related to

Sort By:
Pageof 38
Contemporary Clinical Trials|March 27, 2024
Getting our ducks in a row: The need for data utility comparisons of healthcare systems data for clinical trialsMatthew R Sydes, Macey L Murray, Saiam Ahmed, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2015
XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer PatientsPetra Seibold, Sabine Behrens, Peter Schmezer, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2022
Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrantLuca Malorni, Svitlana Tyekucheva, Florentine S Hilbers, et al.
The Journal of Infectious Diseases|October 23, 2014
Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individualsSusanne H Hodgson, Katie J Ewer, Carly M Bliss, et al.
The Journal of Infectious Diseases|June 17, 2016
Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAPTommy Rampling, Katie J Ewer, Georgina Bowyer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 24, 2012
ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humansSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
Pediatric Research|January 8, 2022
Neonatal sepsis: a systematic review of core outcomes from randomised clinical trialsCían J Henry, Gergana Semova, Ellen Barnes, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2017
Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and InfantsCarly M Bliss, Abdoulie Drammeh, Georgina Bowyer, et al.
Lancet (London, England)|February 20, 2007
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trialR C Coombes, L S Kilburn, C F Snowdon, et al.
Plos One|March 26, 2013
Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adultsCaroline Ogwang, Muhammed Afolabi, Domtila Kimani, et al.
Pageof 38